|
Participant demographics and clinical characteristics
| | |
|
N
|
142
|
|
Female, n (%)
|
87 (61%)
|
|
Age, median years (IQR)
|
32 (28, 38)
|
|
Weight, median kg (IQR)
|
46 (41, 51)
|
|
BMI, median kg/m2 (IQR)
|
16 (15, 19)
|
|
CD4+count, median cells/mm3L (IQR)
|
34 (21, 47)
|
|
Hemoglobin, median g/dL (IQR)
|
9.8 (8.8, 11.6)
|
|
Baseline serum biomarker levels
| | |
|
Phosphate, median mmol/L (IQR)
|
1.26 (1.03, 1.42)
|
[range 0.4-2.3]
|
|
Albumin, median g/L (IQR)
|
29.5 (23.9, 33.2)
|
[range 13.1-49.5]
|
|
Ferritin, median μg/L (IQR)
|
221 (59, 485)
|
[range 4-1332]
|
|
hsCRP, median mg/L (IQR)
|
2.8 (1.1, 15.2)
|
[range 0.2-58.3]
|
|
ART regimen, n (%)
| | |
|
ZDV/3TC/EFV
|
8 (6%)
|
|
ZDV/3TC/NVP
|
34 (24%)
|
|
d4T/3TC/EFV
|
15 (11%)
|
|
d4T/3TC/NVP
|
62 (44%)
|
|
TDF/FTC/EFV
|
4 (3%)
|
|
TDF/FTC/NVP
|
19 (13%)
|
